Metabolism Cases I Flashcards
Glutathione is synthesized from what amino acids? What is it’s significance? Does it need ATP for it’s synthesis? Reduction of glutathione (SS -> 2-SH) requires what? What two enzyme deficiences can contribute to decreased function of glutathione?
Glutathione is an antioxidant (ie. it is reduced and can reduce an ROS) and neutralizes reactive oxygen species (ROS). Synthesized from glutamate, cysteine and glycine with ATP as it’s power source. Enzymes: G6PD and pryuvate Kinase deficies contribute to decreased function of glutathione. Reduction of glutathion requeires NADPH!
Ribose-5-P is produced by the oxidative branch of the HMP shunt. Why is nucleotide biosynthesis not compromised in individuals with G6PD deficiency?
Ribose 5-P can also be produced via HMP shunt-nonoxidative branch-reverse direction. The nonoxidative branch-reverse direction allows the nonoxidative pathway to generate ribose-5-P without the need for 6PD. If it were not for this, a deficiency in G6PD might prove to be more lethal.
Common events that result from oxidative damage to RBCs
- Heinz bodies (found in association with G6PD deficieny; consis of Hb covalently bound to plasma membrane lipids)
- Rigidity of cytoskeleton (signal for premature destruction in the spleen)
- Increased RBC removal results in hemolytic anemia and/or hemolytic jaundice)
Events that may increase oxidative stress in erythrocytes
- infections: macrophages produce H2O2 as a killing mechanism. This is the most common cause of hemolysis associated with G6PD deficiency.
- oxidant drugs (such as antibiotic Bactrim, generate free oxygen radicals (ROS) that are destroyed in a reaciton catalyzed by the endogenous enzyme superoxide disumuatse (SOD). The product of this rxn is H2O2
- Fava beans: contain compounds that indirectly stimulate the production of H2O2, much like that of oxidant drugs (favism is a form of G6PD deficiency, but not all G6PD=deficiencies manifest after fava bean ingestion)
The PK deficiency that produces hemolytic anemia is RBC-specific. Individuals with G6PD deficiency have a defect of this enzyme in all cells, but only the RBCs are affected. Explain why RBCs are the only cell type to show pathology.
In RBCs, and other cells without mitochondria, the sole source of NADPH is the HMP shunt oxidative branch. Glutathione reduction is impaired because of decreased NADPH availability.
In liver and muscle, which do have mitochondria, malic enzyme can also be used to produce NADPH. This NADPH can then be used in the reduction of glutathione.
G6PD deficiency Impaired production of: Impact on glutathione production: Impact on GS-SG/G-SH ratio: Impact on H2O2 levels: Types of hemolysis (acute or chronic)
Impaired production of: NADPH
Impact on glutathione production: Unchanged
Impact on GS-SG/G-SH ratio: Increased
Impact on H2O2 levels: increased
Types of hemolysis (acute or chronic): acute (induced by cellular oxidative stress)
PK deficiency: Impaired production of: Impact on glutathione production: Impact on GS-SG/G-SH ratio: Impact on H2O2 levels: Types of hemolysis (acute or chronic)
Impaired production of: ATP
Impact on glutathione production: decreased
Impact on GS-SG/G-SH ratio: unchanged
Impact on H2O2 levels: increased
Types of hemolysis (acute or chronic): chronic (caused by ATP debt and reduced glutathione levels) as well as Acute (by induced cellular oxidation stress)
PK deficiency: what results in the reduction of ATP synthesis? In PK deficiency is hemolysis a chronic or acute condition?
The chronic reduction of ATP synthesis impairs many proteins and cellular functions, including:
-Na+/K+-ATPase: Ion imbalance and osmotic stress
-Biosynthesis of glutathione: Increased oxidative stress
Like G6PD deficiency, the resulting RBC rigidity results in premature erythrocyte destruction
(i.e., hemolysis) by the spleen. In PK deficiency, however, this hemolysis is a chronic condition
that can occur even in the absence of external stresses (infection, drugs, etc.)
Do individuals with RBC-specific PK deficiency experience acute or chronic hemolytic
anemia? Why?
Chronic . PK deficiency -> chronic ATP deficit in RBCs -> reduced activity of Na+-K+-
ATPase and decreased production of glutathione -> increase in H2O2 levels -> membrane
damage -> hemolysis.
Would you expect a PK-deficient individual to suffer increased hemolysis in response to
infection? Why or why not?
Yes. In addition to chronic hemolysis, decreased levels of glutathione will impair the ability of PK deficient RBCs to adequately detoxify H2O2, thus inducing more oxidative stress.
Explain how bactrim treatment may result in hemolytic anemia in a G6PD-deficient patient.
Bactrim treatment may indirectly result in the increased production of H2O2. Individuals with G6PD deficiency cannot produce adequate amounts of NADPH. Under stress, glutathione disulfide (G-S-S-G) cannot be reduced back to G-SH. A decrease in G-SH will result in increased H2O2 accumulation. (this would also happen in a patient with PK deficiency)
Why didn’t the patient experience chronic hemolytic anemia in the absence of Bactrim
treatment?
Individuals with G6PD deficiency typically retain 40-50% of normal G6PD activity. This level of activity is sufficient to prevent oxidative stress under non-aggravating conditions.
Why does a person with cytochrome b5 reductase deficiency need to avoid exposure to compounds/foods that contain nitrites (NO2-) or nitrates (NO3 -)?
Nitrites and nitrates are oxidants that lead to production of methemoglobin. Exposure (topical or oral ingestion) to these compounds can lead to increased methemoglobinemia. In individuals with congenital cause of methemoglobinemia such as a cytochrome b5 reductase deficiency should be extra cautious with these agents that can exacerbate the existing methemoglobinemia
If someone has a cytochrome b5 reductase deficiency, what is the treatment of choice? Will this treatment work as well with someone who also has a G6PD deficiency?
No. The methylene blue treatment will not work effectively. An inadequate supply of NADPH due to G6PD deficiency will result in a decrease in reduction of methylene blue (less leukomethylene blue to reduce MetHb). As a result, MetHb concentration will be high. Methylene blue therapy is contraindicated in G6PD deficient patients, since the MB will consume NADPH.
Cytochrome b5 reductase uses NADH or NADPH?
NADH!